Minor drug-resistant HIV type-1 variants in breast milk and plasma of HIV type-1-infected Ugandan women after nevirapine single-dose prophylaxis

Antiviral Therapy

Volumn 16, Issue 1, 2011, Pages 109-113

  Pilger, Daniel ^a   Hauser, Andrea ^a,b   Kuecherer, Claudia ^b   Mugenyi, Kizito ^c   Kabasinguzi, Rose ^c   Somogyi, Sybille ^b   Harms, Gundel ^a   Kunz, Andrea ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b ROBERT KOCH INSTITUTE   (Germany)

^c Gesellschaft für Technische Zusammenarbeit mbH   (Uganda)

Author keywords

[No Author keywords available]

Indexed keywords

NEVIRAPINE;

ADULT; ALLELE; ARTICLE; BREAST MILK; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN TISSUE; NONHUMAN; PLASMA; PRIORITY JOURNAL; SINGLE DRUG DOSE; UGANDA; VIRUS GENOME; VIRUS MUTATION;

ADULT; ANTI-HIV AGENTS; COHORT STUDIES; DRUG RESISTANCE, VIRAL; FEMALE; GENETIC VARIATION; HIV INFECTIONS; HIV-1; HUMANS; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MILK, HUMAN; MUTATION; NEVIRAPINE; POST-EXPOSURE PROPHYLAXIS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; UGANDA;

EID: 79951471667     PISSN: 13596535     EISSN: None     Source Type: Journal    
DOI: 10.3851/IMP1698     Document Type: Article

References (25)

1. World Health Organization. HIV transmission though breastfeeding: a review of available evidence. Geneva: World Health Organization 2004.
2. Guay LA, Musoke P, Fleming T, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet 1999; 354:795-802. (Pubitemid 29415583)
3. Eshleman SH, Guay LA, Mwatha A, et al. Comparison of nevirapine (NVP) resistance in Ugandan women 7 days vs. 6-8 weeks after single-dose NVP prophylaxis: HIVNET 012. AIDS Res Hum Retroviruses 2004; 20:595-599. (Pubitemid 38813656)
4. Eshleman SH, Hoover DR, Chen S, et al. Nevirapine (NVP) resistance in women with HIV-1 subtype C, compared with subtypes A and D, after the administration of single-dose NVP. J Infect Dis 2005; 192:30-36. (Pubitemid 40863854)
5. Flys TS, Donnell D, Mwatha A, et al. Persistence of K103N-containing HIV-1 variants after single-dose nevirapine for prevention of HIV-1 mother-to-child transmission. J Infect Dis 2007; 195:711-715.
6. Flys TS, McConnell MS, Matovu F, et al. Nevirapine resistance in women and infants after first versus repeated use of single-dose nevirapine for prevention of HIV-1 vertical transmission. J Infect Dis 2008; 198:465-469.
7. Johnson JA, Li JF, Morris L, et al. Emergence of drug-resistant HIV-1 after intrapartum administration of single-dose nevirapine is substantially underestimated. J Infect Dis 2005; 192:16-23. (Pubitemid 40863852)
8. Loubser S, Balfe P, Sherman G, Hammer S, Kuhn L, Morris L. Decay of K103N mutants in cellular DNA and plasma RNA after single-dose nevirapine to reduce mother-to-child HIV transmission. AIDS 2006; 20:995-1002.
9. Palmer S, Boltz V, Martinson N, et al. Persistence of nevirapine-resistant HIV-1 in women after single-dose nevirapine therapy for prevention of maternal-to-fetal HIV-1 transmission. Proc Natl Acad Sci U S A 2006; 103:7094-7099.
10. Lockman S, McIntyre JA. Reduction of HIV-1 drug resistance after intrapartum single-dose nevirapine. Lancet 2007; 370:1668-1670. (Pubitemid 350100774)
11. Flys TS, Chen S, Jones DC, et al. Quantitative analysis of HIV-1 variants with the K103N resistance mutation after single-dose nevirapine in women with HIV-1 subtypes A, C, and D. J Acquir Immune Defic Syndr 2006; 42:610-613. (Pubitemid 44162432)
12. Moorthy A, Gupta A, Bhosale R, et al. Nevirapine resistance and breast milk HIV transmission: effects of single and extended-dose nevirapine prophylaxis in subtype C HIV-infected infants. PLoS ONE 2009; 4:e4096.
13. Kassaye S, Lee E, Kantor R, et al. Drug resistance in plasma and breast milk after single-dose nevirapine in subtype C HIV type 1: population and clonal sequence analysis. AIDS Res Hum Retroviruses 2007; 23:1055-1061. (Pubitemid 47492348)
14. Lee EJ, Kantor R, Zijenah L, et al. Breast-milk shedding of drug-resistant HIV-1 subtype C in women exposed to single-dose nevirapine. J Infect Dis 2005; 192:1260-1264. (Pubitemid 41368427)
15. Hudelson SE, McConnell MS, Bagenda D, et al. Emergence and persistence of nevirapine resistance in breast milk after single dose nevirapine administration. AIDS 2010; 24:557-561.
16. Kunz A, Frank M, Mugenyi K, et al. Persistence of nevirapine in breast milk and plasma of mothers and their children after single-dose administration. J Antimicrob Chemother 2009; 63:170-177.
17. Hauser A, Mugenyi K, Rose K, et al. Detection and quantification of minor HIV-1 variants harbouring K103N and Y181C resistance mutations in subtype A and D isolates by allele-specific real-time PCR. Antimicrob Agents Chemother 2009; 53:2965-2973.
18. de Oliveira T, Deforche K, Cassol S, et al. REGA HIV-1 automated subtyping tool. (Accessed 15 November 2010.) Available from http://jose.med. kuleuven.be/genotypetool/html/subtypinghiv.html
19. PHYLIP. (Accessed 15 November 2010.) Available from http://evolution.gs. washington.edu/phylip.html
20. Los Alamos HIV Database. (Accessed 15 November 2010.) Available from http://www.hiv.lanl.gov/content/sequence/NEWALIGN/align.html
21. BioEdit. Version 7.0.5. (Accessed 15 November 2010.) Available from http://www.mbio.ncsu.edu/BioEdit/bioedit.html
22. John-Stewart G, Mbori-Ngacha D, Ekpini R, et al. Breast-feeding and transmission of HIV-1. J Acquir Immune Defic Syndr 2004; 35:196-202. (Pubitemid 38133745)
23. Andreotti M, Guidotti G, Galluzzo CM, et al. Resistance mutation patterns in plasma and breast milk of HIV-infected women receiving highly-active antiretroviral therapy for mother-to-child transmission prevention. AIDS 2007; 21:2360-2362. (Pubitemid 350287471)
24. McIntyre JA, Hopley M, Moodley D, et al. Efficacy of short-course AZT plus 3TC to reduce nevirapine resistance in the prevention of mother-to-child HIV transmission: a randomized clinical trial. PLoS Med 2009; 6:e1000172.
25. Rousseau CM, Nduati RW, Richardson BA, et al. Longitudinal analysis of human immunodeficiency virus type 1 RNA in breast milk and of its relationship to infant infection and maternal disease. J Infect Dis 2003; 187:741-747. (Pubitemid 36286934)